Stay connected and up-to-date on the latest news and reports. It’s never been easier to know what’s going on in digital health.
2024 has been off to a great start at HealthXL, with topics ranging from Tech Enabled Change in Oncology Workflows to a Masterclass: The Legacy of Pear Therapeutics
Read more
ViVE has always been an essential event for digital health decision-makers, offering invaluable insights into the evolving landscape of healthcare.
Read more
2024 has been off to a great start at HealthXL, with topics ranging from How to Scale Partnerships Between Lifesciences and Digital Health Companies? to Real World Data in Clinical Trials: Benefits and Best Practices.
Read more
AI holds the promise of revolutionising clinical trials, specifically by automating and optimising critical processes. The technology has the capability to significantly boost productivity, cut costs, and accelerate the overall timeline of clinical trials.
Read more.png)
Many of you may still be relishing in the holiday bliss, but for HealthXL, the new year is already in full swing. Before we properly close the door on last year, I wanted to take a minute (or so …) to reflect on the tumultuous year that has been.
Read more
As the year draws to a close so does our AI spotlight series. The series catered to many different interests with topics and conversations focused on themes such as Does AI Guarantee ROI and Revolutionising Pharma: AI's Impact on the Value Chain.
Read more
The HealthXL community convened in Princeton, New Jersey. In collaboration with Otsuka, HealthXL organised its fourth Global Gathering of the year around the theme of Leveraging Data-Driven Strategies for Improving Patient Experience.
Read more
By embracing digital measures, pharma can accelerate drug development and improve patient outcomes. Pharma can and will continue to compete on assets, but should not compete on (digital) endpoints. We require industry collaborations in order to usher in a new era of medicine.
Read more
It's been another month of great events at HealthXL, with topics ranging from Enhancing Patient Experiences with Data-Driven Insights to PDT 2.0: The Future of Prescription Digital Therapeutics. To make sure you don't miss the top insights from our community meetings, here are my top five takeaways.
Read more
In a recent masterclass, the discussion revolved around approaches, scalability, and accessibility of digital health solutions in GLP-1 medication and obesity management. In this article, we highlight the key insights shared during the session.
Read moreIn a recent masterclass, the discussion revolved around approaches, scalability, and accessibility of digital health solutions in GLP-1 medication and obesity management. In this article, we highlight the key insights shared during the session.
Read more
Introducing new technologies into healthcare settings can be challenging. For example, outdated systems, such as paper-based processes for imaging, can hinder the adoption of new digital health solutions. The medical field can improve treatment and care by deploying new technologies. Additionally e
Read more.png)
It's been another month of great events at HealthXL, with topics ranging from Pharma 3.0 and how to do digital health better, to the role medical affairs in the age of digitalisation. Here are my top six takeaways from HealthXL meetings that took place over the past two months.
Read more
Few would argue that medical affairs plays a strategic role for digital health in pharma, despite their strategic positioning between commercial and R&D. This new report reevaluates the role of medical affairs in pharma and asks what may be holding them back from a greater role in digital health.
Read more.png)
The HealthXL team has returned to Dublin from Gothenburg following yet another successful Global Gathering, this time in collaboration with AstraZeneca. The resounding consensus on the day was that tech in clinical trials will work.
Read more
It's been another month of great events at HealthXL, with topics ranging from ‘DTx Reimbursement: Navigating Medicare & Medicaid Coverage’ to ‘Quantifying the Benefits of Digital Biomarkers in Pharma’.
Read more
In recent years, medical affairs has slowly been brought into the digital era with the introduction of tracking tools and new virtual channels for communication with health care practitioners HCPs. Patients' needs and expectations are also changing rapidly.
Read more
With marketing leaders from across leading pharma organisations, Steve Peretz, Healthcare Practice Lead, Digital Products, Appnovation and Angela Rosales, Group Director, Strategy, Appnovation, led the session to share key insights into evolving product approaches with an ecosystem strategy, empower
Read more